KCTD12 modulation of GABA(B) receptor function
AuthorLi, M; Milligan, CJ; Wang, H; Walker, A; Churilov, L; Lawrence, AJ; Reid, CA; Hopkins, SC; Petrou, S
Source TitlePharmacology Research and Perspectives
PublisherJOHN WILEY & SONS LTD
University of Melbourne Author/sPetrou, Steven; Churilov, Leonid; Lawrence, Andrew; Li, Melody; Reid, Christopher; Walker, Andrew; Milligan, Carol
AffiliationFlorey Department of Neuroscience and Mental Health
Medicine (Austin & Northern Health)
Document TypeJournal Article
CitationsLi, M., Milligan, C. J., Wang, H., Walker, A., Churilov, L., Lawrence, A. J., Reid, C. A., Hopkins, S. C. & Petrou, S. (2017). KCTD12 modulation of GABA(B) receptor function. PHARMACOLOGY RESEARCH & PERSPECTIVES, 5 (4), https://doi.org/10.1002/prp2.319.
Access StatusOpen Access
The molecular composition and functional diversity of native GABAB receptors (GABABR) are still poorly understood, thus hindering development of selective GABABR ligands. Potassium channel tetramerization domain-containing protein (KCTD) 12 is a GABABR auxiliary subunit and mouse KCTD12 can alter GABABR function. In this study, we sought to characterize the effects of human KCTD12 on GABABR kinetics and pharmacology, using an automated electrophysiological assay. Seizure susceptibility and ethanol consumption were also investigated in a KCTD12 knockout mouse model. Human KCTD12 co-expression altered the kinetics of GABABR-mediated GIRK channels, speeding rates of both activation and desensitization. Analysis of concentration-response curves showed that KCTD12 coexpression did not alter effects of the agonists GABA or baclofen on GABABR. KCTD12 coexpression enhanced the potentiating effects of the positive allosteric modulator CGP7930, and its effects on GABABR activation and desensitization. The function of KCTD12 in vivo was examined, using the KCTD12 knockout mouse model. The knockout mice were more resistant to a pentylenetetrazole proconvulsant challenge suggesting reduced seizure susceptibility. In the two bottle preference test, KCTD12 knockout mice demonstrated a reduced consumption at high ethanol concentrations. In summary, human KCTD12 accelerated the kinetics of GABABR in vitro, in a manner possibly sensitive to allosteric pharmacological modulation. This study also provides novel in vivo evidence that the interaction between KCTD12 and GABABR is of physiological significance, and may be a mechanism to more selectively modulate GABABR.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References